also the rate of blastic transformation is similar for patients receiving hydroxyurea at first , and arabinosyl cytosine ( ara-c ) , vincristine ( vcr ) and prednisone ( p ) thereafter , as for patients receiving from the clinical onset of cml a more intensive chemotherapy with ara-c , thioguanine ( tg ) and daunomycin ( dauno ) , but not vcr + p .
C0020402
first
C0023473
cml